Novateor Research Laboratories share price
BSE: 542771Personal ProductsSmall Cap
Novateor Research Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2019
Last close ₹43.00up ₹5.00 (13.16%)
Share price at the BSE close on 26 Oct 2026. Previous close ₹38.00.
26 Oct: open ₹43.00, high ₹43.00, low ₹43.00
52-week range of traded prices to 26 Oct 2026
₹20.08Low, 9 Dec 2025₹43.00High, 26 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr4,190th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 239.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,000
Results
Standalone; ₹ crore.Novateor Research Laboratories half-yearly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +37.8%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +32.9%
Half year to Mar 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹1.36 Crdown 45.04%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- ₹0.12 CrHalf year to Sep 2025: −₹0.01 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 8.6%
Revenue by half year
Peak revenue ₹2.47 Cr, half year to Sep 2025; lowest ₹0.36 Cr, half year to Sep 2023
Net profit by half year, a loss in red
- Net profit
- Loss
Back to profit in the half year to Mar 2026, ₹0.12 CrA loss in 1 of the 8 half years shown
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.82 | 0.44 | 0.36 | 0.85 | 0.79 | 1.98 | 2.47 | 1.36 |
| Net profit | 0.01 | 0.03 | 0.01 | 0.02 | 0.03 | 0.05 | −0.01 | 0.12 |
| Net margin | 0.8% | 6.9% | 1.4% | 2.8% | 4.2% | 2.4% | −0.3% | 8.6% |
Standalone. The last eight half years. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹3.83 Crup 37.81%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.10 Crup 23.72%
- Net margin
- 2.6%
Revenue by year
Peak revenue ₹3.83 Cr, year to Mar 2026; lowest ₹0.19 Cr, year to Mar 2021
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 2 of the 7 years shown
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.39 | 0.19 | 0.74 | 1.26 | 1.21 | 2.78 | 3.83 |
| Net profit | −0.01 | 0.01 | −0.23 | 0.04 | 0.03 | 0.08 | 0.10 |
| Net margin | −2.0% | 6.3% | −30.8% | 2.9% | 2.4% | 2.9% | 2.6% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Oral Care Products, which carries all its revenue.
Novateor Research Laboratories competitors and peers
Personal Care, 21 listed companies, priced on 30 Oct 2026. The table lists the 8 companies closest to Novateor Research Laboratories in market cap. Novateor Research Laboratories' own figures are from its last trade, on 26 Oct 2026. 2 companies in the table last traded before then: their rows are priced on their last trade.FMCG companies
Where the company sits among the companies nearest its size
| Company | |||||||
|---|---|---|---|---|---|---|---|
 Macobs TechnologiesMACOBSTECH | 192 | 66.12 | 4.62 | – | 8.3% | – | 0.00% |
 H. R. Hygiene ProductsHRHYGIENE | 137 | – | – | – | – | – | 0.00% |
 Aakaar Medical TechnologiesAAKAAR | 101 | 15.16 | 1.84 | – | 12.2% | – | 0.00% |
 Thrive Future HabitatsTHRIVE | 88 | – | 1.66 | −29.8% | −5.3% | −6.8% | 0.00% |
 JHS Svendgaard LaboratoriesJHS | 70 | – | 0.40 | +19.4% | −1.1% | −2.3% | 0.00% |
 RavelcareRAVEL | 61 | 11.82 | 1.63 | – | 13.8% | – | 0.00% |
 Medistep HealthcareMEDISTEP | 28 | 4.63 | 0.73 | – | 15.8% | – | 0.00% |
 Paramount Cosmetics (India)PARMCOS-B | 17 | 77.25 | 0.83 | −5.9% | 1.1% | 1.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Novateor Research Laboratories announcements
Oct 2026
15 Oct · Non Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015
1 Oct · Meeting
Sep 2026
29 Sep · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Novateor Research Laboratories annual report, year to Mar 2026
Novateor Research Laboratories share price by year
Each calendar year to 2025.Novateor Research Laboratories share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 24.00 | −44.0% | 57.50 | 20.08 |
| 2024 | 42.85 | +22.4% | 53.27 | 35.50 |
| 2023 | 35.00 | +75.0% | 35.00 | 16.00 |
| 2022 | 20.00 | +100.2% | 20.00 | 7.70 |
| 2021 | 9.99 | +128.1% | 16.26 | 4.53 |
| 2020 | 4.38 | −77.7% | 18.70 | 3.40 |
| 2019 | 19.65 | – | 48.40 | 19.65 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 17 Jan 2025. 2019 is from its first session, 13 Sep 2019. The 2022 close is its last trade, on 15 Dec 2022.
Recent sessions
The 9 trading days to 23 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 33.90 | 38.00 | 33.90 | 38.00 | 35.95 | 6,000 |
| 21 Oct 2026 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 3,000 |
| 16 Oct 2026 | 30.00 | 39.00 | 30.00 | 39.00 | 34.50 | 6,000 |
| 28 Sep 2026 | 37.50 | 37.50 | 37.50 | 37.50 | 37.50 | 3,000 |
| 7 Sep 2026 | 35.00 | 35.10 | 35.00 | 35.10 | 35.05 | 6,000 |
| 31 Aug 2026 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 3,000 |
| 12 May 2026 | 32.85 | 32.85 | 32.85 | 32.85 | 32.85 | 3,000 |
| 7 May 2026 | 32.65 | 32.65 | 32.65 | 32.65 | 32.65 | 12,000 |
| 6 May 2026 | 32.40 | 32.40 | 32.40 | 32.40 | 32.40 | 3,000 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 9 Dec 2025 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 11 Mar 2025 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 5 Feb 2025 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 29 May 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- BSE code
- 542771
- ISIN
- INE08JY01013
- Industry
- Personal Products
- Website
- www.novateor.com
- CIN
- L24230GJ2011PLC064731
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2011
- Registered office
- 1026, Dev Atelier, Opp. Dev Aurum, Anandnagar Cross Road, 100 Feet Ring Road, Prahladnagar, Ahmedabad 380015, Gujarat
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments